Related references
Note: Only part of the references are listed.Does Radiation Have a Role in Advanced Stage Hodgkin's or Non-Hodgkin Lymphoma?
Lena Specht
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
Re-Examining the Role of Radiation Therapy for Diffuse Large B-Cell Lymphoma in the Modern Era
Andrea K. Ng et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736
Deborah M. Stephens et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma
Frederika A. van Nimwegen et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Radiotherapy of indolent orbital lymphomas Two radiation concepts
Laila Koenig et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2016)
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
H. Tilly et al.
ANNALS OF ONCOLOGY (2015)
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma
Antonio Omuro et al.
BLOOD (2015)
What is the optimal management of early-stage low-grade follicular lymphoma in the modern era?
John A. Vargo et al.
CANCER (2015)
Masses in the mediastinum: primary mediastinal lymphoma and intermediate types
Peter W. M. Johnson
HEMATOLOGICAL ONCOLOGY (2015)
Predictors of Radiation Pneumonitis in Patients Receiving Intensity Modulated Radiation Therapy for Hodgkin and Non-Hodgkin Lymphoma
Chelsea C. Pinnix et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2015)
Treatment Selection and Survival Outcomes in Early-Stage Diffuse Large B-Cell Lymphoma: Do We Still Need Consolidative Radiotherapy?
John A. Vargo et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Final Results of a Prospective Evaluation of the Predictive Value of Interim Positron Emission Tomography in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP-14 (SAKK 38/07)
Christoph Mamot et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology
Khe Hoang-Xuan et al.
LANCET ONCOLOGY (2015)
Proton therapy in the management of non-Hodgkin lymphoma
Suzanne Sachsman et al.
LEUKEMIA & LYMPHOMA (2015)
Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?
Andrea Janikova et al.
LEUKEMIA & LYMPHOMA (2015)
Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma
Michael Schaapveld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Stereotactic Radiosurgery in the Treatment of Recurrent CNS Lymphoma
Ravi Kumar et al.
WORLD NEUROSURGERY (2015)
FDG PET-CT in follicular lymphoma: a case-based evidence review
Stephen D. Smith et al.
BLOOD (2015)
Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide
Mary R. Welch et al.
LEUKEMIA & LYMPHOMA (2015)
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M. Dreyling et al.
ANNALS OF ONCOLOGY (2014)
Coronary Artery Disease Detected by Coronary Computed Tomography Angiography in Adult Survivors of Childhood Hodgkin Lymphoma
Daniel A. Mulrooney et al.
CANCER (2014)
Radiotherapy of Follicular Lymphoma: Updated Role and New Rules
Joachim Yahalom
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2014)
Modern Radiation Therapy for Nodal Non-Hodgkin Lymphoma-Target Definition and Dose Guidelines From the International Lymphoma Radiation Oncology Group
Tim Illidge et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Sally F. Barrington et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Role of Radiotherapy to Bulky Disease in Elderly Patients With Aggressive B-Cell Lymphoma
Gerhard Held et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Breast Cancer After Chest Radiation Therapy for Childhood Cancer
Chaya S. Moskowitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non- inferiority trial
Peter J. Hoskin et al.
LANCET ONCOLOGY (2014)
The vanishing role of whole brain radiotherapy for primary central nervous system lymphoma
Michael Weller
NEURO-ONCOLOGY (2014)
Radiation-induced second malignancies after involved-node radiotherapy with deep-inspiration breath-hold technique for early stage Hodgkin Lymphoma: a dosimetric study
Uwe Schneider et al.
RADIATION ONCOLOGY (2014)
Dosimetric advantages of a butterfly technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin's lymphoma
Khinh Ranh Voong et al.
RADIATION ONCOLOGY (2014)
Radiotherapy (4 Gy vs. 24 Gy) of Patients with indolent Non-Hodgkin-Lymphoma
Klaus Herfarth et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2014)
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions A Scientific Statement From the American Heart Association
Steven E. Lipshultz et al.
CIRCULATION (2013)
Recommendations for the Use of Radiotherapy in Nodal Lymphoma
P. J. Hoskin et al.
CLINICAL ONCOLOGY (2013)
Low-Dose Radiation Therapy (2 Gy x 2) in the Treatment of Orbital Lymphoma
Carolina E. Fasola et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Impact of Rituximab and Radiotherapy on Outcome of Patients With Aggressive B-Cell Lymphoma and Skeletal Involvement
Gerhard Held et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Rituximab, Methotrexate, Procarbazine, and Vincristine Followed by Consolidation Reduced-Dose Whole-Brain Radiotherapy and Cytarabine in Newly Diagnosed Primary CNS Lymphoma: Final Results and Long-Term Outcome
Patrick G. Morris et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles
David Cunningham et al.
LANCET (2013)
Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial
Richard Delarue et al.
LANCET ONCOLOGY (2013)
Dose-Adjusted EPOCH-Rituximab Therapy in Primary Mediastinal B-Cell Lymphoma
Kieron Dunleavy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Minimising critical organ irradiation in limited stage Hodgkin lymphoma: a dosimetric study of the benefit of involved node radiotherapy
B. A. Campbell et al.
ANNALS OF ONCOLOGY (2012)
Interim 18-FDG-PET/CT failed to predict the outcome in diffuse large B-cell lymphoma patients treated at the diagnosis with rituximab-CHOP
Patrizia Pregno et al.
BLOOD (2012)
Chemotherapy Alone for Localized Diffuse Large B-Cell Lymphoma
Laurie H. Sehn
CANCER JOURNAL (2012)
DOSIMETRIC BENEFITS OF INTENSITY-MODULATED RADIOTHERAPY COMBINED WITH THE DEEP-INSPIRATION BREATH-HOLD TECHNIQUE IN PATIENTS WITH MEDIASTINAL HODGKIN'S LYMPHOMA
Amaury Paumier et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Management of Localized-Stage Follicular Lymphoma: Changing the Paradigm?
Silvia Montoto
JOURNAL OF CLINICAL ONCOLOGY (2012)
Effectiveness of First-Line Management Strategies for Stage I Follicular Lymphoma: Analysis of the National LymphoCare Study
Jonathan W. Friedberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Different IMRT solutions vs. 3D-Conformal Radiotherapy in early stage Hodgkin's lymphoma: dosimetric comparison and clinical considerations
Christian Fiandra et al.
RADIATION ONCOLOGY (2012)
Treatment of limited stage follicular lymphoma with Rituximab immunotherapy and involved field radiotherapy in a prospective multicenter Phase II trial-MIR trial
Mathias Witzens-Harig et al.
BMC CANCER (2011)
PALLIATION BY LOW-DOSE LOCAL RADIATION THERAPY FOR INDOLENT NON-HODGKIN LYMPHOMA
Elisa K. Chan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Whole-brain radiotherapy in primary CNS lymphoma
Andres J. M. Ferreri et al.
LANCET ONCOLOGY (2011)
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2011)
Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination
Andres J. M. Ferreri et al.
ONCOLOGIST (2011)
Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trial
Lisa Lowry et al.
RADIOTHERAPY AND ONCOLOGY (2011)
Primary Central Nervous System Lymphoma
Elizabeth R. Gerstner et al.
ARCHIVES OF NEUROLOGY (2010)
InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions
Jennifer J. Turner et al.
BLOOD (2010)
Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte
Bertrand Coiffier et al.
BLOOD (2010)
Improved Survival in Patients With Early Stage Low-Grade Follicular Lymphoma Treated With Radiation A Surveillance, Epidemiology, and End Results Database Analysis
Thomas J. Pugh et al.
CANCER (2010)
Risk-Adapted Dose-Dense Immunochemotherapy Determined by Interim FDG-PET in Advanced-Stage Diffuse Large B-Cell Lymphoma
Craig H. Moskowitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Role of Cancer Treatment in Long-Term Overall and Cardiovascular Mortality After Childhood Cancer
Markhaba Tukenova et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial
Eckhard Thiel et al.
LANCET ONCOLOGY (2010)
Follicular Lymphoma in the United States: First Report of the National LymphoCare Study
Jonathan W. Friedberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
Andres J. M. Ferreri et al.
LANCET (2009)
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas:: a randomised controlled trial (RICOVER-60)
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2008)
CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients:: A study by the Groupe d'Etude des Lymphomes de I'Adulte
Christophe Bonnet et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Impact of involved field radiotherapy in partial response after doxorubicin-based chemotherapy for advanced aggressive non-Hodgkin's lymphoma
Elizabeth C. Moser et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma:: a randomised controlled trial by the MabThera International Trial (MInT) Group
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2006)
Long-term outcome and mortality trends in early-stage, Grade 1-2 follicular lymphoma treated with radiation therapy
BA Guadagnolo et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Pretreatment with rituximab enhances radiosensitivity of non-Hodgkin's lymphoma cells
I Skvortsova et al.
JOURNAL OF RADIATION RESEARCH (2005)
ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma
F Reyes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern cooperative oncology group study 1484
SJ Horning et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas
RLM Haas et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma
KJ Savage et al.
BLOOD (2003)
Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2
JS Miller et al.
BLOOD (2001)
Share Paper
